Fiji Kava Ltd. announced the appointment of Dr. Anthony Noble as its new Chief Executive Officer. Dr. Noble is currently the Managing Director and CEO of Australian Biotherapeutics. Dr. Noble has spent a decade working at global natural healthcare company SFI Health, which specialises in microbiome and cognitive health. Anthony served in several roles including Managing Director of SFI Research, Global Head of Innovation, and Head of North Asia, GM of their Chinese Joint Venture and Global Head of Business to Business. The appointment will take effect from 31 May 2021, enabling a seamless transition from Mr. Nicholas Simms who has been acting as interim CEO. Mr. Simms and Mr. Yoshida will both continue as a Non- Executive Directors on the Fiji Kava Board.